BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17535296)

  • 1. Tumor suppressor p16INK4a--modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells.
    André S; Sanchez-Ruderisch H; Nakagawa H; Buchholz M; Kopitz J; Forberich P; Kemmner W; Böck C; Deguchi K; Detjen KM; Wiedenmann B; von Knebel Doeberitz M; Gress TM; Nishimura S; Rosewicz S; Gabius HJ
    FEBS J; 2007 Jul; 274(13):3233-56. PubMed ID: 17535296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour suppressor p16(INK4a) - anoikis-favouring decrease in N/O-glycan/cell surface sialylation by down-regulation of enzymes in sialic acid biosynthesis in tandem in a pancreatic carcinoma model.
    Amano M; Eriksson H; Manning JC; Detjen KM; André S; Nishimura S; Lehtiö J; Gabius HJ
    FEBS J; 2012 Nov; 279(21):4062-80. PubMed ID: 22943525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor p16 INK4a: Downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model.
    Sanchez-Ruderisch H; Fischer C; Detjen KM; Welzel M; Wimmel A; Manning JC; André S; Gabius HJ
    FEBS J; 2010 Sep; 277(17):3552-63. PubMed ID: 20695889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor p16INK4a controls oncogenic K-Ras function in human pancreatic cancer cells.
    Rabien A; Sanchez-Ruderisch H; Schulz P; Otto N; Wimmel A; Wiedenmann B; Detjen KM
    Cancer Sci; 2012 Feb; 103(2):169-75. PubMed ID: 22049925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1.
    Valenzuela HF; Pace KE; Cabrera PV; White R; Porvari K; Kaija H; Vihko P; Baum LG
    Cancer Res; 2007 Jul; 67(13):6155-62. PubMed ID: 17616672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
    Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
    Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-transfection of p16(INK4a) and p53 genes into the K562 cell line inhibits cell proliferation.
    Rui HB; Su JZ
    Haematologica; 2002 Feb; 87(2):136-42. PubMed ID: 11836163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
    Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel function for the tumor suppressor p16(INK4a): induction of anoikis via upregulation of the alpha(5)beta(1) fibronectin receptor.
    Plath T; Detjen K; Welzel M; von Marschall Z; Murphy D; Schirner M; Wiedenmann B; Rosewicz S
    J Cell Biol; 2000 Sep; 150(6):1467-78. PubMed ID: 10995450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
    Leong WF; Chau JF; Li B
    Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of p16INK4a tumor suppressor is upregulated by human cytomegalovirus infection and required for optimal viral replication.
    Zannetti C; Mondini M; De Andrea M; Caposio P; Hara E; Peters G; Gribaudo G; Gariglio M; Landolfo S
    Virology; 2006 May; 349(1):79-86. PubMed ID: 16504234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P16INK4a expression adenovirus vector to suppress pancreas cancer cell proliferation.
    Kobayashi S; Shirasawa H; Sashiyama H; Kawahira H; Kaneko K; Asano T; Ochiai T
    Clin Cancer Res; 1999 Dec; 5(12):4182-5. PubMed ID: 10632358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) induces apoptotic processes in pancreatic carcinoma cells.
    Kemmner W; Kessel P; Sanchez-Ruderisch H; Möller H; Hinderlich S; Schlag PM; Detjen K
    FASEB J; 2012 Feb; 26(2):938-46. PubMed ID: 22049060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of the expression of beta1,4-galactosyltransferase V promotes integrin beta1 maturation.
    Chen X; Jiang J; Yang J; Chen C; Sun M; Wei Y; Guang X; Gu J
    Biochem Biophys Res Commun; 2006 May; 343(3):910-6. PubMed ID: 16564504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant.
    Carcel-Trullols J; Stanley JS; Saha R; Shaaf S; Bendre MS; Monzavi-Karbassi B; Suva LJ; Kieber-Emmons T
    Int J Oncol; 2006 May; 28(5):1173-83. PubMed ID: 16596233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between expression and methylation status of p16INK4a and the proliferative activity of different areas' tumour cells in human colorectal cancer.
    Jie G; Zhixiang S; Lei S; Hesheng L; Xiaojun T
    Int J Clin Pract; 2007 Sep; 61(9):1523-9. PubMed ID: 17537196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a gene-dependent effect on the cell surface glycan profile.
    Patsos G; André S; Roeckel N; Gromes R; Gebert J; Kopitz J; Gabius HJ
    Glycobiology; 2009 Jul; 19(7):726-34. PubMed ID: 19293232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered N-glycosylation in CD45 and regulatory roles of altered N-glycosylation in galectin-1-induced growth inhibition in human diffuse large B cell lymphoma.
    Suzuki O; Nozawa Y; Abe M
    Oncol Rep; 2005 Jan; 13(1):109-14. PubMed ID: 15583810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-1 knocking down in human U87 glioblastoma cells alters their gene expression pattern.
    Camby I; Decaestecker C; Lefranc F; Kaltner H; Gabius HJ; Kiss R
    Biochem Biophys Res Commun; 2005 Sep; 335(1):27-35. PubMed ID: 16051185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P; Zaravinos A; Zioga M; Spandidos DA
    Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.